EMEA-000463-PIP02-10
Key facts
| Invented name |
Glivec
|
| Active substance |
Imatinib (mesilate)
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/85/2011
|
| PIP number |
EMEA-000463-PIP02-10
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of pulmonary arterial hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Limited
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|